46 results about "Paranasal sinusitis" patented technology

Devices, systems and methods for stenting, spacing, draining, ventilating and / or delivering drugs and other therapeutic or diagnostic substances to desired locations within the bodies of human or non-human animal subjects, including methods and systems for treating paranasal sinusitis and ethmoid disease.

Devices, systems and methods for stenting, spacing, draining, ventilating and / or delivering drugs and other therapeutic or diagnostic substances to desired locations within the bodies of human or non-human animal subjects, including methods and systems for treating paranasal sinusitis and ethmoid disease.

Disclosed herein is a composition and a method for the treatment of otitis media and paranasal sinusitis using human defensins, lysozyme and / or lactoferrin as a new class of non-antibiotic antimicrobials. From studies of otitis media and paranasal sinusitis, it was observed that certain innate immune modulators were important in the bodies response to the infection. Therefore, these innate immune modulators, lysozyme, lactoferrin, and defensins were tested for use as a non-antibiotic treatment for infection, particularly infections such as otitis media and sinusitis.

The invention discloses a pharmaceutical composition for curing allergic rhinitis. The pharmaceutical composition is mainly prepared by extracting the following effective components of a dozen of medical materials including white peony root, astragalus root, white atractylodes rhizome, ledebouriella root, Chinese angelica, magnolia flower, schisandra fruit, grassleaved sweetflag rhizome, cicada slough, liquorice, asarum, dark plum, cocklebur fruit, and the like. The specific active components of the pharmaceutical composition have the effects of strengthening spleen and supplementing qi, warmly nourishing kidney-yang and stopping tears and have remarkable therapeutic effects of curing the rhinitis and various symptoms such as acute and chronic rhinitis, paranasal sinusitis, sicca and atrophic rhinitis, and the like caused by common cold and other reasons.

The invention relates to the technical field of traditional Chinese medicines, particularly a traditional Chinese medicine for treating sinusitis. The traditional Chinese medicine for treating sinusitis is characterized by mainly comprising the following active pharmaceutical ingredients in parts by weight: 5-15 parts of cocklebur fruit, 1-15 parts of magnolia flower, 5-9 parts of thymeleaf sandwort, 4-10 parts of radix angelicae, 5-10 parts of burdock fruit, 10-25 parts of self-heal, 4-9 parts of herba schizonepetae, 2-5 parts of fructus gleditsiae, 3-10 parts of chastetree fruit, 5-10 parts of mulberry leaf, 3-9 parts of Japanese sweetflag, 5-10 parts of radix sileris and 3-9 parts of cassia twig. By compounding the active pharmaceutical ingredients, the traditional Chinese medicine for treating sinusitis has the functions of expelling wind and cold pathogens, clearing the nasal cavity, reducing the stagnation and promoting the subsidence of swelling. Thus, the traditional Chinese medicine for treating sinusitis has the effects of quickly curing sinusitis, paranasal sinusitis, sinus cyst and rhinopolypus, has the advantages of obvious curative effect and no toxic or side effect, and is convenient to use; and the effective rate is 100%, and the cure rate is 98%.

The invention discloses a traditional Chinese medicinal composition for treating rhinitis and paranasal sinusitis and a preparation method thereof. The traditional Chinese medicinal composition contains the following raw materials of: by weight, 10-25 parts of cocklebur, 8-20 parts of flos magnolia, 6-18 parts of wild chrysanthemum flower, 6-18 parts of Saposhnikovia divaricata, 4-15 parts of mint, 3-10 parts of perilla, 3-10 parts of Vitex trifolia L, 3-10 parts of catnip, 2-8 parts of bidens, 2-8 parts of Andrographis paniculata Nees, 2-8 parts of Yedo violet, 2-8 parts of honeysuckle flower, 2-8 parts of madder and 1-6 parts of licorice. The invention also discloses a preparation method of the traditional Chinese medicinal composition and its application in the preparation of medicines for treating rhinitis and paranasal sinusitis. It shows through clinical observation that the traditional Chinese medicinal composition has definite and reliable therapeutic effects of treating rhinitis and paranasal sinusitis, and is safe in the clinical usage, and has no toxic and side effect.

The invention discloses a traditional Chinese patent medicine for treating rhinitis, and contains the following raw medicines by weight part: 100-200 parts of pine pollen, 80-150 parts of bulbus fritilariae, 50-100 parts of Chinese caterpillar fungus, 200-300 parts of horn filament, 50-100 parts of hemlock parsley and 80-150g of biond magnolia flower. When in production, all raw materials are crushed, screened, mixed evenly, and then prepared into capsule, pill, pulvis or troche. Proved by practice, the invention has reasonable prescription, significant curative effect but small toxic and side effects, can treat both symptoms and root cause, and is suitable for the patients with allergic rhinitis, chronic simple rhinitis, nasosinusitis, paranasal sinusitis, etc., cure rate can reach 90.7 percent and total obvious effective rate can reach 98.4 percent and diseases are not likely to recur after curing. Generally, patients can recover after 2-4 months of treatment. The medicine has low cost, simple process and is easy for generalization and application. .

The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof.

The invention discloses a traditional Chinese medicine decoction for treating chronic paranasal sinusitis and a preparation method thereof. The traditional Chinese medicine decoction mainly consists of honeysuckle, platycodon grandiflorus, angelica dahurica, radix paeoniae rubra, lotus rhizome node, siberian cocklour fruit, divaricate saposhnikovia root, acorus gramineus, gardenia, liquorice, wrinkled gianthyssop herb, magnolia flower and mint. The traditional Chinese medicine composition has the effects of stopping pain and smoothening the nose, has the effect of well relieving various pain symptoms and stuffy noses and running noses caused by the chronic paranasal sinusitis and has the obvious effect of treating the chronic paranasal sinusitis.

A Chinese traditional medicine for curing chronic paranasal sinusitis belongs to the Chinese traditional medicine for curing paranasal sinusitis. The ingredients of the medicine (with weights) are siberian cocklebur fruit 15g, biond magnolia flower 9g, mint 6g, angelica 15g, notopterygium root 10g, chuanxiong rhizome 10g, asarum 3g, honeysuckle 15g, chrysanthemum 15g, heartleaf houttuynia herb 30g and glabrous greenbrier rhizome 30g; the auxiliary ingredients include shrub chastetree fruit 15g under the situation of serious headache; chinese lovage 15g under the situation of headache on the head top; bupleur 10g under the situation of painful temple; root of lobed kudzuvine 20g under the situation of pain on the top; ageratum 10g, scutellaria root 10g and coptis root 6g under the situation of anorexia and greasy fur; grassleaf sweetflag rhizome 10g and snakegourd fruit 15g under the situation of much tears and sputum. The composition of the medicine is simple and medicines used in the prescription are all natural herbs; the fetching and use of the materials are convenient and the manufacture method is simple; the effect is excellent and the price is low; in this way, the herbal medicine is especially fit for people living in remote villages far away from counties and towns; the curing expense for patients with the disease of chronic paranasal sinusitis is low which solves the problem that the household income is low and the life is poor and the medical conditions is deficient locally.

The invention relates to a medicament for treating paranasal sinusitis, which is a capsule product prepared by the following steps: evenly mixing the prepared cocklebur fruit with honeysuckle, flowerbud of lily magnolia, astragalus mongholicus, scutellaria baicalensis, gypsum, radix angelicae, ligusticum wallichii, adlay, red paeony root, platycodon grandiflorum, fructus aurantii, fructus forsythiae, peach kernel, red flower, fructus viticis and liquorice; adding water to decoct and condensing the mixture to paste; drying, smashing and packing to the capsule; sterilizing and disinfecting to obtain the capsule product. The medicament has the advantages of expelling wind and cold pathogens, clearing away heat and toxic material, clearing sinus, removing blood stasis and apocenosis, strengthening the body resistance to eliminate pathogenic factors. The medicament is reliable, rapid and convenient to treat paranasal sinusitis and is safe to take, and the effective rate thereof is 97.0% according to clinic observation.

The invention discloses a pharmaceutical composition for curing rhinitis and a preparation method thereof. The pharmaceutical composition is mainly prepared by extracting the following effective components of a dozen of medical materials including magnolia flower, cidcada slough, ptunella spike, moutan bark, cape jasmine, frosythia fruit, liquorice, arctium fruit, peppermint, almond, anemarrhena rhizome, lilyturf root, common reed rhizome, dark plum, Chinese angelica, schizonepta, and the like. The specific active components of the pharmaceutical composition have the effects of warming lung and spleen, clearing away heat and toxic material, promoting Qi and activating blood, excreting dampness to remove nasal discharge and nourishing yin to mositen dryness and have remarkable therapeutic effects of curing various symptoms such as acute and chronic rhinitis, paranasal sinusitis, allergic rhinitis, sicca and atrophic rhinitis and nasal polyp caused by common cold and other reasons.

Disclosed is a mandible teeth fixing oral device enabling the mandible to naturally move even when the oral device, to be fixed to the mandible teeth, is worn. The mandible teeth fixing oral device according to one embodiment comprises: a body having a shape corresponding to a set of teeth; a lower groove formed at the lower part of the body such that the mandible teeth are inserted therein; an upper groove formed at the upper part of the body such that the maxilla teeth are inserted therein so as to allow the maxilla to retract at a predetermined distance; and a maxilla tooth guide part formed to extend from the body so as to face the lateral side of the maxilla teeth, wherein the lower groove further includes: a mandible posterior tooth fixing groove formed so as to allow at least one part of the left and right molars of the mandible teeth to strongly engage with each other through frictional force; and a mandible anterior tooth groove formed so as to hold the remaining mandible teeth excluding the left and right molars. When the oral device for fixing the mandible teeth is used, aches, malocclusion, or a temporomandibular joint disorder do not occur, unlike in a conventional oral device, even when the oral device is worn, and the flow of air through the airway is smooth such that sleep apnea, snoring, rhinitis, or paranasal sinusitis can be relieved.

The invention belongs to the novel technology field of the medicines and relates to a preparation and use of a ceftibuten dry suspension. The ceftibuten dry suspension is characterized by comprising, but not being limited by following excipients available by pharmacy: sucrose, mannitol, etc. as the loading agent; sodium chloride, aspartame, strawberry essence, etc. as the flavoring agent; carbomer, sodium carboxymethyl cellulose, sodium carboxy nethyl, etc. as the suspending agent. The ceftibuten dry suspension is used for treating: upper respiratory tract infection such as pharyngitis, antiaditis, scarlet fever, paranasal sinusitis, and otitis medium; lower respiratory tract infection such as acute bronchitis, acute attack of chronic bronchitis and pneumonia; urinary tract infection; enteritis and gastroenteritis.

The invention particularly relates to a traditional Chinese medicine for treating paranasal sinusitis. The traditional Chinese medicine for treating paranasal sinusitis is mainly prepared from the following active pharmaceutical ingredients in parts by weight: 5-15 parts of cocklebur fruit, 1-15 parts of magnolia flower, 5-9 parts of thymeleaf sandwort, 4-10 parts of radix angelicae, 5-10 parts of burdock fruit, 10-25 parts of self-heal, 4-9 parts of herba schizonepetae, 2-5 parts of fructus gleditsiae, 3-10 parts of chastetree fruit, 5-10 parts of mulberry leaf, 3-9 parts of Japanese sweetflag, 5-10 parts of radix sileris, 3-9 parts of cassia twig, 9-15 parts of celery cabbage root, 3-9 parts of radix bupleuri, 5-10 parts of cicada ecdysis, 1-3 parts of musk, 0.3-1 part of storax, 6-12 parts of red paeonia, 10-20 parts of motherwort, 3-9 parts of dried orange peel and 10-15 parts of balloonflower. By compounding the active pharmaceutical ingredients, the traditional Chinese medicine for treating paranasal sinusitis has the functions of expelling wind and cold pathogens, clearing the nasal cavity, reducing the stagnation and promoting the subsidence of swelling. The traditional Chinese medicine for treating paranasal sinusitis has the advantages of obvious curative effect and no toxic or side effect, and is convenient to use; and the effective rate is 100%, and the cure rate is 96.8%.

The invention relates to an oral traditional Chinese medicine and external application traditional Chinese medicine combined medicine for treating various types of rhinitis, wherein the oral traditional Chinese medicine comprises more than 20 traditional Chinese medicines such as milkvetch root, manchurian wildginger herb, divaricate saposhnikovia, tall gastrodia rhizome, heartleaf houttuynia herb and the like, and the external application traditional Chinese medicine comprises more than 10 traditional Chinese medicines such as coptis chinensis, angelica archang lica, wasps nest, cow-bezoar, pearl powder and the like. According to the present invention, the medicine is the secret recipe inherited for six generations, and clinical improvement is performed for near several decades so as to provide significant treatment effects; clinical trial and treatment results of 560 acute rhinitis and chronic rhinitis patients in the local Chinese medicine hospitals, maternal and child health hospitals, and attached hospitals to medical colleges show that the total effective rate is 96% and a cure rate is 91%; and the oral traditional Chinese medicine and external application traditional Chinese medicine combined medicine provides significant treatment effects for allergic rhinitis, chronic rhinitis, hypertrophic rhinitis, chronic sinusitis, paranasal sinusitis, nasal vestibulitis, atrophic rhinitis and turbinate hypertrophy, wherein the oral-external application combined treatment manner is adopted so as to achieve a symptom and root cause treatment effect.

The invention provides a nasal spray which is composed of, by weight, 8-10 parts of small centipeda herb, 6-7 parts of flos magnolia, 12-15 parts of menthol, 34-51 parts of seawater, 5-7 parts of plant cellulose, 1-2 parts of isoosmotic adjusting agent, 1-2 parts of scutellaria baicalensis, 6-8 parts of sophora flavescens, 5-8 parts of mint and 5-7 parts of agastache rugosus. Compared with the prior art, the nasal spray has the advantages that the small centipeda herb can treat nasal obstruction and nasosinusitis, menthol is used as a stimulant pharmaceutically, acts on skin or mucosa and has effects of cooling and stopping itching, can treat acute and chronic rhinitis, allergic rhinitis, hypertrophic rhinitis, nasosinusitis and paranasal sinusitis, and other medicinal excipients are added, so that the nasal spray is protruding in treatment effect, high in healing rate, simple, convenient, cheap and easy to clinically popularize.

The invention belongs to the field of traditional Chinese medicine and particularly relates to a traditional Chinese medicine for treating rhinitis and a preparation method thereof. The traditional Chinese medicine comprises fructus xanthii, rhizoma chuanxiong, flos magnoliae, radix angelicae dahuricae, ovateleaf holly bark, Calvatia gigantea fruiting body, radix trichosanthis, fructus piperis longi, cortex phellodendri, honeysuckle flower bud, radix scutellariae, Euphorbia kansui root, fructus gleditsiae, semen brassicae, fructus bruceae, rhizoma corydalis, indigo naturalis, herba ecliptae and asarum. The traditional Chinese medicine is prepared by processes such as soaking and decocting. The traditional Chinese medicine materials of the traditional Chinese medicine directly act on nose lesions and are capable of expelling and eliminating pus, fast removing nose lesion inflammation and radically curing various rhinitis, and the traditional Chinese medicine is convenient, efficient, short in treatment cycle, low in relapse rate and free of side effects and dependency. Clinical practice of the traditional Chinese medicine on over ten thousand people shows that the traditional Chinese medicine is definite in curative effect on allergic rhinitis, nasosinusitis, paranasal sinusitis, nasal polyp, acute and chronic rhinitis and turbinate hypertrophy, low in cost, good in effect, lowin use amount and free of side effects.

A traditional Chinese medicine composition for treating rhinitis and a preparation method thereof. The invention belongs to the technical field of traditional Chinese medicines and provides the traditional Chinese medicine composition for treating rhinitis, which is quick to act, short in treatment course, good in effects, low in toxic and side effects, not liable to cause relapse and low in cost, and the preparation method thereof. The traditional Chinese medicine composition includes, by weight, 120-180 parts of centipeda minima, 20-40 parts of flos magnolia, 10-30 parts of radix angelicae dahuricae, 20-30 parts of fructus xanthii, 3-5 parts of divaricate saposhnikovia roots, 3-8 parts of borneol and 0.01-0.05 parts of halite violaceous. The traditional Chinese medicine composition is quick to act, short in treatment course, low in toxic and side effects, not liable to cause relapse and low in cost, has excellent treatment effects on chronic simple rhinitis, chronic hypertrophic rhinitis, chronic paranasal sinusitis, allergic rhinitis and nasal polyp, and is more than 95% in effective rate and more than 75% in curative rate.

The invention discloses a Chinese traditional medicine composition for clearing heat-toxicity and eliminating dampness and a preparation method thereof. The Chinese traditional medicine composition is mainly prepared by extracting the following effective components of a dozen of medical materials including indian bread, dandehon herb, frosythia fruit, pilose asiabell root, cimicifuga rhizome, belamcanda rhizome, wrinkled gianthyssop, pangolin, spina gleditsiae, nidus vespae, dahurian angelica root, tangerine peel, cordate houttuynia, goldthread root, cape jasmine, ptunella spike, kudzuvine root, and the like. The specific active components of the composition have the effects of clearing heat-toxicity, eliminating dampness and discharging pus to be sensible, is clinically used for stuffy nose, runny yellow viscous nose, acute and chronic rhinitis and paranasal sinusitis and can also obviously improve various symptoms of stuffy nose, dizziness and distending pain, nasal secretions increase, sinus nasalis area tendeness, deviated nasal septum, and the like.

The invention relates to a traditional Chinese medicine preparation for nursing patients suffering from rhinitis and a preparation method thereof. Effective constituents of the traditional Chinese medicine preparation comprise asarum, magnolia delavayi, corn silk, pothos chinensis, cocklebur, lily magnolia, grass-leaved sweetflag rhizome, perilla root, soda-apple night-shade herb, cowry shell, balloonflower root, torpedograss root and rhizome, passionflower, otolhum pseudoscinaenae, bunge corydalis herb and aneurolepidium root. The traditional Chinese medicine preparation is a pure Chinese herbal medicine, is prepared by the advanced pharmaceutical technology, has effects of dispelling wind and facilitating lung, dredging acupoint and diminishing inflammation, and dispelling the wind and bringing down a fever, has obvious effects of treating allergic rhinitis, chronic rhinitis, atrophic rhinitis, nasosinusitis, nasal polyp and acute or chronic paranasal sinusitis, has a short treatment course, produces effects fast, is safe and nontoxic and has total rhinitis treatment efficiency more than 90%.

The invention belongs to the technical field of traditional Chinese medicine and pharmacy, and particularly relates to a rhinitis pressurized spray and a preparation method thereof. The rhinitis pressurized spray comprises the following raw materials in parts by weight of 20-30 parts of radix scutellariae, 20-30 parts of fried siberian cocklebur fruits, 20-30 parts of mint, 10-15 parts of radix angelicae, 10-13 parts of divaricate saposhnikovia roots, 5-10 parts of small centipeda herbs, 5-10 parts of licorice roots and 10-15 parts of fineleaf schizonepeta herbs, and auxiliary materials of 10gof sodium chloride, 1.5g of anhydrous sodium sulfite, 100g of glycerine and an appropriate amount of Tween-80 are also added to the raw materials. The rhinitis pressurized spray has the advantages that distilled water is used as a solvent, and irritants caused to nasal mucosa due to the adoption of an organic solvent are avoided; according to the characteristics and the nature of main active substances, volatile substances are collected, then extraction is performed, in the extraction process, the water addition amount, the decoction time, the number of times of decoction, the density of paste and the like are researched, the situation that effective ingredients are not lost in the process of the preparation is guaranteed, and the quality and the treatment effects of final products are guaranteed; and in addition, the rhinitis pressurized spray has favorable treatment effects on symptoms of stuffy noses, headache, foreign body sensation of the nasal cavity and the like caused by allergic rhinitis and paranasal sinusitis.

The invention relates to a lomefloxacin aspartate hydrate and the preparation, as well as the usage. The lomefloxacin aspartate hydrate of the invention (the molecular formula is C17H19F2N3O3.C4H7NO4.nH2O, n is equal to 0.5 to 2.5), the lomefloxacin aspartate hydrate of the invention is the fluoroquinolone antibacterial agent used for human or animal respiratory infection, genitourinary infection, gastrointestinal tract bacterial infection, abdominal infection, bile duct infection, typhoid and other infections, bone and joint infection, skin soft tissue infection, sepsis and other systemic infection, other infections, such as paranasal sinusitis, otitis media, blepharitis and so on which are caused by Gram positive or negative bacteria and sensitive bacteria, the invention has the advantages of stable existence, easy storage and transportation and convenient preparation of the pharmaceutical preparations.

The invention relates to a Chinese patent medicine compound preparation and particularly relates to a compound preparation for treating rhinosinusitis. The compound preparation is characterized by containing the water extract and decoction of fresh and mature fig, arborvitae tops, echinacea, baikal skullcap root, cocklebur fruit and liquorice, then ethanol precipitation is carried out, the supernatant liquid is taken and concentrated into clear paste, and the clear paste, sucrose and dextrin are uniformly mixed and then dried to be prepared into tablets or particles. The compound preparation provided by the invention has the functions of clearing away heat and toxic material, reducing swelling and alleviating pain, expelling wind and removing dampness, purging fire for removing toxin, promoting blood circulation and arresting bleeding, enhancing the immunity and resistance of the organism, improving symptoms and promoting nasal cavity and nasal sinus mucosa functions, and does not have toxic and side effects. Clinical applications prove that the compound preparation provided by the invention has obvious curative effects on postoperative recovery of acute and chronic rhinitis, paranasal sinusitis, rhinopharyngitis and nose and sinus parts, adjuvant therapy of malignant tumors at the parts and especially postoperative radiotherapy of patients, and has the obvious advantages of good performance, easiness in preparation, low cost, no toxic and side effects and the like.

The invention relates to a magnetooptic source for nasal cavity physical therapy and is auxiliary of magnetooptic nasal through instrument and magnetooptic blood through instrument with high viscidity and lipid. It comprises red / blue bicolor LED tube, ring-type permanent magnet, external casing and connection pedestal. Photomagnetic energy can permeate schneiderian membrane for absorption, relieve inflammatory, decrease swelling, recover function of mucous cell, reduce blood viscosity and blood lipid, activate multiple enzymes to scavenge free radical, and improve local and cerebral blood circulation. It can be be used for the treatment of different kinds of rhinitis, paranasal sinusitis, hyperviscous hyperlipemia and auxiliary treatment of cerebral infarction. It has convenient and simple operation which comprises putting magnetooptic source in nasal cavity, connecting light source wire with micromainframe, and settling treatment time, and pulse continuation mode.

The invention discloses a medicament for treating paranasal sinusitis and a preparation method of the medicament. The medicament is mainly prepared from medicines such as magnolia flower, lotus rhizoma node, artemisia capillaries, fructus viticis, antelope horn, radix semiaquilegiae, houttuynia cordata, cassia twig and the like according to a certain weight ratio. The medicament disclosed by the invention has the functions of clearing away heat and toxic materials and dispelling the wind and removing stasis, and is rapid to take an effect, good in curative effect, free of reoccurrence and free of side effect when used for treating paranasal sinusitis.

The invention relates to a medicine for treating rhinitis and belongs to the technical field of traditional Chinese medicines. The medicine is prepared from the following raw materials: fried cocklebur fruits, radix angelicae, boxthorn roots, magnolia flower powder, caulis spatholobi, perilla leaves, towel gourd roots, bean seed-coat, fructus viticis, myrobalan pulp, codonopsis pilosula, rhizoma smilacis glabrae, scorched hawthorn fruits and liquorice. The medicine for treating rhinitis provided by the invention is reasonable in formula, can treat both symptoms and root causes and is suitable for patients with allergic rhinitis, chronic simple rhinitis, nasosinusitis, paranasal sinusitis and the like, small in toxic and side effects and remarkable in curative effect. The cure rate can reach up to over 90%, and the effective dosage is over 97%. Common patients can be cured within 0.5-1 month, so that the treatment course is short. The medicine is low in cost, simple to process and easy to popularize and apply.